Penrhos Bio raise £1m Seed funding to accelerate development of the Remora™️ technology, and is joined as an investment partner by Eos Advisory.
Penrhos Bio has secured the second tranche of its £1m Seed funding round, and is pleased to welcome Eos Advisory as investment partners. This investment, including the first tranche in 2021, takes the business through to its Series A raise in 2023, and accelerates our business development pipeline.
for the press release see:
AmpliSpec™ LAB BVDV is Biotangents’ first next generation molecular diagnostic assay for the detection of BVDV in cattle. Its unique design combines LAMP technology, lyophilised bead technology and Biotangents’…
Cellexus have partnered with Castleford-based Verder Liquids to provide pumps to be used for the acid / base pump, included as standard with the CellMaker Plus and Low Flow bioreactor systems.
First product launched with Remora® technology to control harmful biofilms at IDS dental trade fare, Germany.
Dxcover Limited today announced it has raised $11.9 (£9.7) million in Series A and grant financing. The funding will support the ongoing development of the Dxcover® Liquid Biopsy Platform for the detection…
Antibody Analytics is excited to announce a strategic partnership with HistologiX, a company specialising in cellular and digital pathology services. As precision medicine is embraced and the number of targeted…
HITRUST Implemented, 1-year Certification validates Relaymed is committed to managing cybersecurity risk and protecting sensitive information Orlando, FL – Relaymed,…
Contact: info@innovapartnerships.com
Terms and Conditions • Web Terms of Use ©2023 Innova Partnerships, All Rights reserved